| Dr Richard William Puschinsky, MD | |
|
624 Quaker Lane, Ste C103, High Point, NC 27262 | |
| (336) 882-0220 | |
| (336) 882-1207 |
| Full Name | Dr Richard William Puschinsky |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 35 Years |
| Location | 624 Quaker Lane, High Point, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245391085 | NPI | - | NPPES |
| 2211486A | Other | NC | PSC MEDICARE PROVIDER |
| 8969535 | Medicaid | NC | |
| 69535 | Other | NC | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 9500428 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| High Point Regional Health System | High point, NC | Hospital |
| Entity Name | Piedmont Stone Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700827409 PECOS PAC ID: 2961315718 Enrollment ID: O20031107000688 |
News Archive
Celsion Corporation announced today that after reviewing safety data from 120 patients enrolled in the pivotal Phase III ThermoDox® clinical trial ("HEAT" trial) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
ChanRx is developing a superior drug for treatment of atrial fibrillation (AFIB), and has closed its Series A funding with investments from Sante Ventures and company founder, Dr. Arthur "Buzz" Brown. The company, a spin out of Cleveland-based ChanTest, will use the funding to further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine.
A new study has shown that children who spend more time in front of television and computer screens and less in outdoor physical activity have narrower blood vessels in their eyes. In adults, constricted blood vessels in the eyes have been linked to an increased risk of cardiovascular disease.
A new method to standardize the reporting of radiation dose volumes in the use of four-dimensional computed tomography (4D-CT) can lead to a more accurate radiation dose to the lungs in lung cancers, thereby lowering the risk of lung injury, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system. Lawmakers are concerned the companies are trying to reap gains ahead of reforms aimed at lowering drug prices and forcing drugmakers to partly fund changes that aim to boost the number of Americans covered by health insurance.
› Verified 9 days ago
| Entity Name | Medical Center Urology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639285943 PECOS PAC ID: 5597807206 Enrollment ID: O20100119000385 |
News Archive
Celsion Corporation announced today that after reviewing safety data from 120 patients enrolled in the pivotal Phase III ThermoDox® clinical trial ("HEAT" trial) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
ChanRx is developing a superior drug for treatment of atrial fibrillation (AFIB), and has closed its Series A funding with investments from Sante Ventures and company founder, Dr. Arthur "Buzz" Brown. The company, a spin out of Cleveland-based ChanTest, will use the funding to further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine.
A new study has shown that children who spend more time in front of television and computer screens and less in outdoor physical activity have narrower blood vessels in their eyes. In adults, constricted blood vessels in the eyes have been linked to an increased risk of cardiovascular disease.
A new method to standardize the reporting of radiation dose volumes in the use of four-dimensional computed tomography (4D-CT) can lead to a more accurate radiation dose to the lungs in lung cancers, thereby lowering the risk of lung injury, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system. Lawmakers are concerned the companies are trying to reap gains ahead of reforms aimed at lowering drug prices and forcing drugmakers to partly fund changes that aim to boost the number of Americans covered by health insurance.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard William Puschinsky, MD 624 Quaker Lane, Ste C103, High Point, NC 27262 Ph: (336) 882-0220 | Dr Richard William Puschinsky, MD 624 Quaker Lane, Ste C103, High Point, NC 27262 Ph: (336) 882-0220 |
News Archive
Celsion Corporation announced today that after reviewing safety data from 120 patients enrolled in the pivotal Phase III ThermoDox® clinical trial ("HEAT" trial) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
ChanRx is developing a superior drug for treatment of atrial fibrillation (AFIB), and has closed its Series A funding with investments from Sante Ventures and company founder, Dr. Arthur "Buzz" Brown. The company, a spin out of Cleveland-based ChanTest, will use the funding to further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine.
A new study has shown that children who spend more time in front of television and computer screens and less in outdoor physical activity have narrower blood vessels in their eyes. In adults, constricted blood vessels in the eyes have been linked to an increased risk of cardiovascular disease.
A new method to standardize the reporting of radiation dose volumes in the use of four-dimensional computed tomography (4D-CT) can lead to a more accurate radiation dose to the lungs in lung cancers, thereby lowering the risk of lung injury, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system. Lawmakers are concerned the companies are trying to reap gains ahead of reforms aimed at lowering drug prices and forcing drugmakers to partly fund changes that aim to boost the number of Americans covered by health insurance.
› Verified 9 days ago
Dr. Paul W. F. Coughlin, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 217-218 Gatewood Ave, High Point, NC 27262 Phone: 336-878-6511 Fax: 336-878-6512 | |
Dr. Bradley J. Stoneking, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 217-218 Gatewood Ave, High Point, NC 27262 Phone: 336-878-6511 Fax: 336-878-6512 | |
Dr. Brian James Budzyn, M.D. Urology Medicare: Medicare Enrolled Practice Location: 218 Gatewood Ave, High Point, NC 27262 Phone: 336-878-6511 | |
Dr. Timothy L. Mullins, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 218 Gatewood Ave, High Point, NC 27262 Phone: 336-878-6511 Fax: 336-878-6512 | |
Katherine Leigh Woodburn, M.D. Urology Medicare: Medicare Enrolled Practice Location: 404 Westwood Ave, High Point, NC 27262 Phone: 336-885-0149 |